Free Trial

Yaron Weber Analyst Performance

Analyst at TD Cowen

Yaron Weber is a stock analyst at TD Cowen across a range of sectors, covering 2 publicly traded companies. Over the past year, Yaron Weber has issued 2 stock ratings, including and buy recommendations. While full access to Yaron Weber's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Yaron Weber's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
2 Last 0 Years
Buy Recommendations
100.00% 2 Buy Ratings
Companies Covered
2 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy100.0%2 ratings
Hold0.0%0 ratings
Sell0.0%0 ratings

the majority (100.0%) have been Buy recommendations.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
2 companies

Yaron Weber, an analyst at TD Cowen, currently covers 2 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
1 company
50.0%
Manufacturing
1 company
50.0%

Yaron Weber of TD Cowen specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
1 company
50.0%
PHARMACEUTICAL PREPARATIONS
1 company
50.0%

Yaron Weber's Ratings History at TD Cowen

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Ascendis Pharma A/S stock logo
ASND
Ascendis Pharma A/S
1/7/2026Reiterated Rating$216.18$325.00Buy
Zymeworks Inc. stock logo
ZYME
Zymeworks
5/20/2025Initiated Coverage$12.30Buy